# Phio Pharmaceuticals Corp.: filings

PHIO · Nasdaq · CIK 1533040 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/phio.md) · [Financials](/companies/phio/financials.md) · [Filings](/companies/phio/filings.md) · [Insiders](/companies/phio/insiders.md)

## Reports and events: 314 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 250, 8-K 193, 10-Q 44, 424B3 34, CORRESP 34, EFFECT 28, SC 13G/A 27, UPLOAD 26, SC 13G 22, DEFA14A 21, S-1 20, S-1/A 20, 3 18, D 17, DEF 14A 17, 424B5 16, 10-K 14, S-8 12, SCHEDULE 13G/A 9, PRE 14A 8, S-3 7, SCHEDULE 13G 5, 424B4 4, 4/A 4, ARS 4, CT ORDER 4, 10-Q/A 3, 3/A 3, 8-A12B 2, 8-K/A 2, CERTNAS 2, POS AM 2, S-1MEF 2, 10-K/A 1, 25-NSE 1, 424B2 1, 8-A12G 1, D/A 1, FWP 1, POS EX 1, RW 1, S-3/A 1, SP 15D2 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 12:41 ET | [8-K](/filings/0001437749-26-032505.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-032505 |
| 2026-09-28 | 20:01 ET | [8-K](/filings/0001437749-26-031337.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-031337 |
| 2026-09-14 | 12:59 ET | [8-K](/filings/0001437749-26-030236.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-030236 |
| 2026-08-14 | 20:04 ET | [DEF 14A](/filings/0001437749-26-027997.md) | Proxy statement, period 2026-09-28 | 0001437749-26-027997 |
| 2026-08-06 | 20:16 ET | [8-K](/filings/0001437749-26-026275.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026275 |
| 2026-08-06 | 20:13 ET | [10-Q](/filings/0001437749-26-026271.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026271 |
| 2026-07-21 | 11:07 ET | [8-K](/filings/0001437749-26-023916.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-023916 |
| 2026-05-07 | 20:23 ET | [10-Q](/filings/0001437749-26-015604.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015604 |
| 2026-05-07 | 20:16 ET | [8-K](/filings/0001437749-26-015590.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-015590 |
| 2026-04-08 | 20:15 ET | [8-K](/filings/0001437749-26-011761.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-011761 |
| 2026-03-30 | 11:15 ET | [8-K](/filings/0001437749-26-010164.md) | 8.01 Other events | 0001437749-26-010164 |
| 2026-03-05 | 21:17 ET | [10-K](/filings/0001437749-26-007078.md) | Annual report, period 2025-12-31 | 0001437749-26-007078 |
| 2026-03-05 | 21:10 ET | [8-K](/filings/0001437749-26-007071.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-007071 |
| 2026-02-18 | 21:01 ET | [8-K](/filings/0001437749-26-004542.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-004542 |
| 2026-02-10 | 12:33 ET | [8-K](/filings/0001437749-26-003575.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-003575 |
| 2026-01-20 | 14:33 ET | [8-K](/filings/0001437749-26-001500.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-001500 |
| 2025-12-23 | 13:50 ET | [8-K](/filings/0001437749-25-038607.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-038607 |
| 2025-11-25 | 21:12 ET | [8-K](/filings/0001437749-25-036329.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-036329 |
| 2025-11-13 | 21:25 ET | [10-Q](/filings/0001437749-25-034857.md) | Quarterly report, period 2025-09-30 | 0001437749-25-034857 |
| 2025-11-13 | 21:20 ET | [8-K](/filings/0001437749-25-034848.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034848 |
| 2025-11-06 | 21:11 ET | [8-K](/filings/0001437749-25-033600.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-033600 |
| 2025-11-03 | 13:01 ET | [8-K](/filings/0001437749-25-032662.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-032662 |
| 2025-10-31 | 14:30 ET | [8-K](/filings/0001437749-25-032512.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-032512 |
| 2025-09-15 | 20:01 ET | [8-K](/filings/0001683168-25-006985.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001683168-25-006985 |
| 2025-09-03 | 12:08 ET | [8-K](/filings/0001683168-25-006641.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-006641 |
| 2025-08-14 | 20:48 ET | [10-Q](/filings/0001683168-25-006174.md) | Quarterly report, period 2025-06-30 | 0001683168-25-006174 |
| 2025-08-14 | 20:23 ET | [8-K](/filings/0001683168-25-006171.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-006171 |
| 2025-07-30 | 20:04 ET | [8-K](/filings/0001683168-25-005523.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-005523 |
| 2025-07-30 | 20:02 ET | [DEF 14A](/filings/0001683168-25-005520.md) | Proxy statement, period 2025-09-11 | 0001683168-25-005520 |
| 2025-07-25 | 17:36 ET | [8-K](/filings/0001683168-25-005392.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-005392 |
| 2025-07-07 | 20:01 ET | [8-K](/filings/0001683168-25-004948.md) | 8.01 Other events | 0001683168-25-004948 |
| 2025-06-26 | 00:46 ET | [8-K](/filings/0001683168-25-004759.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-004759 |
| 2025-06-12 | 11:49 ET | [8-K](/filings/0001683168-25-004421.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-25-004421 |
| 2025-05-15 | 20:34 ET | [10-Q](/filings/0001683168-25-003719.md) | Quarterly report, period 2025-03-31 | 0001683168-25-003719 |
| 2025-05-15 | 20:31 ET | [8-K](/filings/0001683168-25-003715.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-003715 |
| 2025-05-07 | 20:15 ET | [8-K](/filings/0001683168-25-003237.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-003237 |
| 2025-04-22 | 20:05 ET | [8-K](/filings/0001683168-25-002725.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001683168-25-002725 |
| 2025-04-09 | 12:20 ET | [8-K](/filings/0001683168-25-002355.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-002355 |
| 2025-03-31 | 20:42 ET | [10-K](/filings/0001683168-25-002134.md) | Annual report, period 2024-12-31 | 0001683168-25-002134 |
| 2025-03-31 | 20:15 ET | [8-K](/filings/0001683168-25-002131.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-002131 |
| 2025-02-20 | 20:02 ET | [8-K](/filings/0001683168-25-001137.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-001137 |
| 2025-01-21 | 21:39 ET | [S-1](/filings/0001683168-25-000460.md) | Registration statement | 0001683168-25-000460 |
| 2025-01-17 | 21:05 ET | [8-K](/filings/0001683168-25-000426.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-000426 |
| 2025-01-15 | 21:05 ET | [8-K](/filings/0001683168-25-000384.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-000384 |
| 2025-01-14 | 22:18 ET | [8-K](/filings/0001683168-25-000347.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-000347 |
| 2025-01-13 | 15:55 ET | [8-K](/filings/0001683168-25-000274.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-000274 |
| 2024-12-26 | 21:05 ET | [8-K](/filings/0001683168-24-008984.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-008984 |
| 2024-12-20 | 21:05 ET | [8-K](/filings/0001683168-24-008884.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-008884 |
| 2024-12-19 | 13:38 ET | [8-K](/filings/0001683168-24-008833.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-008833 |
| 2024-11-14 | 21:49 ET | [10-Q](/filings/0001683168-24-008120.md) | Quarterly report, period 2024-09-30 | 0001683168-24-008120 |

Page 1 of 7. [Older](/companies/phio/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.